Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2015-05-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Active Range of Motion
Early Active Range of Motion (EAROM) 3-9 days following hand fracture
Early Active Range of Motion
3-9 days
Standard Immoblization
Standard immobilization with plaster splint for 21-27 following hand fracture
Standard Immobilization
21-27 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early Active Range of Motion
3-9 days
Standard Immobilization
21-27 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Fifth metacarpal neck fracture, 9 or fewer days since injury
3. Equal or less than 40 degrees of dorsal fracture angulation on lateral x-ray. Angle is measured between the line along the longitudinal axis of the metacarpal shaft and the line from the centre of the metacarpal head to the fracture site.
4. No angulation or malrotation
5. No clinical fracture shortening (ie. Inability to extend fifth digit)
6. Non-operative treatment
7. Volar or ulnar gutter splint (MCP flexed, IPs extended)
Exclusion Criteria
2. "Open fracture" with soft tissue loss overlying fracture site
3. Tendon injury
4. Neurovascular injury
5. Clinical rotatory malalignment
6. Fracture shortening demonstrated by "pseudoclawing"
7. Other fracture in the ipsilateral upper extremity
8. Any operative indication
9. Previous fracture to the involved fifth ray
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamilton Health Sciences Corporation
OTHER
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael James Cooper, MD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamilton General Hospital
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIF-2013-07
Identifier Type: -
Identifier Source: org_study_id